다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Phytomedicine : international journal of phytotherapy and phytopharmacology, v.23 no.7, 2016년, pp.770 - 783
Amsterdam, J.D. , Panossian, A.G.
AI-Helper
Background: Rhodiola rosea (R. rosea) is a botanical adaptogen with putative anti-stress and antidepressant properties. Evidence-based data supporting the effectiveness of R. rosea for depression in adults is limited, and therefore a comprehensive review of available animal and human studies suggest...
J. Affect. Disord. Amsterdam 46 151 1997 10.1016/S0165-0327(97)00086-4 Breast enlargement during chronic SSRI therapy
New Engl. J. Med. Angell 339 839 1998 10.1056/NEJM199809173391210 Alternative Medicine-The Risks of Untested and Unregulated Remedies
Anthony 1992 Handbook of Mental Health and Aging The epidemiology of selected mental disorders in late life
J. Psychiatr. Neurosci Barden 29 185 2004 Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression
Adv. Data Barnes 343 1 2004 Complementary and alternative medicine use among adults: United States, 2002
Arch. Gen. Psychiatr. Beck 4 561 1961 10.1001/archpsyc.1961.01710120031004 An inventory for measuring depression
Psychol. Women Q Belle 27 101 2003 10.1111/1471-6402.00090 Poverty, inequity, and discrimination as sources of depression among U.S. women
Biol. Psychiatr. Blendy 59 1144 2006 10.1016/j.biopsych.2005.11.003 The role of CREB in depression and antidepressant treatment
Blumenthal 1998 The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines
Phytomedicine Boon-Niermeijer 7 389 2000 10.1016/S0944-7113(00)80060-4 Phyto-adaptogens protect against environmental stress-induced death of embryos from the freshwater snail Lymnaea stagnalis
Brichenko 2 58 1986 The use of herbal adaptogens together with tricyclic antidepressants in patients with psychogenic depressions
HerbalGram Brown 56 40 2002 Rhodiola rosea: a phytomedicinal overview
J. Psychiatr. Pract Brown 7 75 2001 10.1097/00131746-200103000-00002 Herbs and nutrients in the treatment of depression, anxiety, insomnia, migraine, and obesity
Pol. J. Pharmacol Budziszewska 54 2002 Effect of antidepressant drugs on the hypothalamic-pituitary-adrenal axis activity and glucocorticoid receptor function
J. Altern. Complement Med Bystritsky 14 175 2008 10.1089/acm.2007.7117 A pilot study of Rhodiola rosea (Rhodax®) for generalized anxiety disorder (GAD)
Tr. Neurosci. Carlezon 28 436 2005 10.1016/j.tins.2005.06.005 The many faces of CREB
Phytomedicine Chen 16 830 2009 10.1016/j.phymed.2009.03.011 The effects of Rhodiola rosea extract on 5-HT level, cell proliferation and quantity of neurons at cerebral hippocampus of depressive rats
Food Chem. Toxicol. Chiang 65 129 2014 10.1016/j.fct.2013.12.032 Hydroalcoholic extract of Rhodiola rosea L. (Crassulaceae) and its hydrolysate inhibit melanogenesis in B16F0 cells by regulating the CREB/MITF/tyrosinase pathway
Ann. NY Acad. Sci. Chrousos 1179 153 2009 10.1111/j.1749-6632.2009.04988.x Glucocorticoid signaling in the cell. Expanding clinical implications to complex human behavioral and somatic disorders
Brain Res. Crespi 1407 27 2011 10.1016/j.brainres.2011.05.033 Influence of Neuropeptide Y and antidepressants upon cerebral monoamines involved in depression: an in vivo electrochemical study
2014 Rhodiola rosea, in Series: Traditional Herbal Medicines for Modern Times
Nord. J. Psychiatr. Darbinyan 61 343 2007 10.1080/08039480701643290 Clinical trial of Rhodiola rosea extract SHR-5 in the treatment of mild to moderate depression
J. Ethnopharmacol Dimpfel 149 583 2013 10.1016/j.jep.2013.07.029 Pharmacological classification of herbal extracts by means of comparison to spectral EEG signatures induced by synthetic drugs in the freely moving rat
Arch. Gen. Psychiatr. De Rubeis 62 409 2005 10.1001/archpsyc.62.4.409 Cognitive therapy vs. medications in the treatment of moderate to severe depression
Arch. Gen. Psychiatr. Druss 57 708 2000 10.1001/archpsyc.57.7.708 Use of practitioner-based complementary therapies by persons reporting mental conditions in the United States
JAMA Eisenberg 280 1569 1998 10.1001/jama.280.18.1569 Trends in alternative medicine use in the United States, 1990-1997 - Results of a follow-up national survey
J. Consult. Clin. Psychol. Elkin 63 841 1995 10.1037/0022-006X.63.5.841 Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program
Extractum Rhodiolae fluidum 1996 Pharmacopoeia article PA 42-2163-96, National Pharmacopoeia Committee
Psychiatr. Serv. Fang 58 402 2007 10.1176/ps.2007.58.3.402 Complementary alternative medicine use among Chinese Americans: findings from a community mental health service population
First 2001 Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition With Psychotic Screen (SCID-I/P W/ PSY SCREEN)
Behav. Brain Funct. Fletcher 6 76 2010 10.1186/1744-9081-6-76 Plasma neuropeptide Y: a biomarker for symptom severity in chronic fatigue syndrome
J. Am. Med. Assoc. Fournier 303 47 2010 10.1001/jama.2009.1943 Antidepressant drug effects and depression severity: A patient-level meta-analysis
Arch. Gen. Psychiatr. Frank 47 1093 1990 10.1001/archpsyc.1990.01810240013002 Three-year outcomes for maintenance therapies in recurrent depression
Gen. Hosp. Psychiatr. Givens 29 182 2007 10.1016/j.genhosppsych.2006.11.002 Ethnicity and preferences for depression treatment
J. Gen. Intern. Med. Givens 22 1292 2007 10.1007/s11606-007-0276-3 Stigma and the acceptability of depression treatments among African Americans and whites
Mol. Cell Endocrinol Grad 275 2 2007 10.1016/j.mce.2007.05.018 The glucocorticoid responses are shaped by molecular chaperones
1976 ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338
J Neurol. Neurosurg. Psychiat. Hamilton 23 56 1960 10.1136/jnnp.23.1.56 A rating scale for depression
Br. J. Med. Psychol. Hamilton 32 50 1959 10.1111/j.2044-8341.1959.tb00467.x The assessment of anxiety status by rating
J. Affect. Discord Hammen 74 49 2003 10.1016/S0165-0327(02)00430-5 Interpersonal stress and depression in women
Eur. J. Pharmacol. Heilig 147 465 1988 10.1016/0014-2999(88)90182-3 Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain
Horm. Metab. Res Hökfelt 31 330 1999 10.1055/s-2007-978748 Galanin and NPY, two peptides with multiple putative roles in the nervous system
Behav. Therapy Hollon 32 235 2001 10.1016/S0005-7894(01)80004-6 Treatment guidelines for major depressive disorder
Psychol. Sci. Pub. Interest Hollon 3 39 2002 10.1111/1529-1006.00008 Treatment and prevention of depression
Mol. Neurobiol Jin 53 851 2016 10.1007/s12035-014-9045-6 Therapeutic intervention of learning and memory decays by salidroside stimulation of neurogenesis in aging
JAMA Jonas 280 1616 1998 10.1001/jama.280.18.1616 Alternative medicine - learning from the past, examining the present, advancing to the future
J. Psychopharmacol. Juruena 27 1169 2013 10.1177/0269881113499205 The role of mineralocorticoid receptor function in treatment-resistant depression
Kaliko 115 1966 Stimulants of the Central Nervous System Effect of Leuzea and Golden Root extracts on dynamic peculiarities of the highest neural performance
Schizophr. Bull. Keith 15 515 1989 10.1093/schbul/15.4.515 U.S. and Soviet perspectives on the diagnosis of schizophrenia and associated dangerousness
J. Clin. Psychiatr. Keller 62 Suppl 24 3 2001 Long-term treatment of recurrent and chronic depression
Altern. Med. Rev. Kelly 6 293 2001 Rhodiaola rosea: a possible plant adaptogen
J. Affect. Disord. Kessler 29 85 1993 10.1016/0165-0327(93)90026-G Sex and depression in the National Comorbidity Survey: I. Lifetime prevalence, chronicity and recurrence
Am. J. Psych. Kessler 158 289 2001 10.1176/appi.ajp.158.2.289 The use of complementary and alternative therapies to treat anxiety and depression in the United States
Ann. Intern. Med Kessler 135 262 2001 10.7326/0003-4819-135-4-200108210-00011 Long-term trends in the use of complementary and alternative medical therapies in the United States
Sci. Rep Kong 5 9009 2015 10.1038/srep09009 STAT3 controls IL6-dependent regulation ofserotonin transporter function and depression-like behavior
Krasik 298 1970 Proceedings Modern Problems in Psycho-Pharmacology Therapy of asthenic conditions: clinical perspectives of application of Rhodiola rosea extract (golden root)
Krasik 215 1970 Proceedings of All-Union and 5th Sverdlovsk Area Conference of Neurobiologists, Psychiatrists and Neurosurgeons About the adaptogenic and stimulating effect of Rhodiola rosea extract
Farm Zurnal Kurkin 20 1231 1986 Chemical composition and pharmacological properties of Rhodiola rosea L. Khim
Pharmacol. Chem. J. Kurkin 40 614 2006 10.1007/s11094-006-0205-5 Antidepressant activity of some phytopharmaceuticals and phenylpropanoids
Methods Find Exp. Clin. Pharmacol. Lazarova 8 547 1986 Effects of meclofenoxate and extr. Rhodiolae rosea L. on electroconvulsive shock-impaired learning and memory in rats
Int. J. Mol. Med Li 32 637 2013 10.3892/ijmm.2013.1434 Salidroside reduces cold-induced mucin production by inhibiting TRPM8 activation
Brain Res. Bull Luo 77 8 2008 10.1016/j.brainresbull.2008.05.010 Involvement of hippocampal serotonin and neuropeptide Y in depression induced by chronic unpredicted mild stress
Phytomedicine Mannucci 19 1117 2012 10.1016/j.phymed.2012.07.001 Serotonin involvement in Rhodiola rosea attenuation of nicotine withdrawal signs in rats
J. Clin. Trials Mao 2014 Rhodiola rosea therapy for major depressive disorder: A study protocol for a randomized, double-blind, placebo- controlled trial
Phytomedicine Mao 22 394 2015 10.1016/j.phymed.2015.01.010 Rhodiola rose vs. sertraline for major depressive disorder: A randomized placebo-controlled trial
Marina 27 1968 Stimulants of the Central Nervous System Effect of Rhodiola rosea extract on bio-electrical activity of the cerebral cortex isolated to a different extent from the brain
Marina 22 1968 Stimulants of the Central Nervous System Effect of Rhodiola rosea extract on electroencephalograms in rabbit
Mashkovskij 1 133 1977 Extractum Rhodiolae fluidum
J. Psychopharmacol. Mattioli 23 130 2009 10.1177/0269881108089872 Effects of Rhodiola rosea L. extract on behavioural and physiological alterations induced by chronic mild stress in female rats
Mesheryakova 180 1975 Materials of Scientific Practical Conference “Problems of rehabilitation of patients with nervous and mental diseases” Tomsk A study of Rhodiola rosea extract effect using the MMPI method
J. Clin. Psychiatr. Meeks 68 1461 2007 10.4088/JCP.v68n1001 Complementary and alternative treatments for late-life depression, anxiety, and sleep disturbance: a review of randomized controlled trials
Psychoneuroendocrinol. Michelson 25 169 2000 10.1016/S0306-4530(99)00046-3 Activation of stress-responsive hormones associated with interruption of selective serotonin reuptake inhibitor treatment
Am. J. Psychiatr. Michelson 156 1170 1999 10.1176/ajp.156.8.1170 Changes in weight during a 1-year trial of fluoxetine in major depression
Mikhailova 126 1983 Current Problems of Psychiatry Clinical and experimental substantiation of asthenic conditions therapy using Rhodiola Rosea extract
Psychiatry Miller 48 13 1985 10.1080/00332747.1985.11024264 The theory and practice of psychiatry in the Soviet Union
Int. J. Neuropsychopharmacol Młyniec 18 3 2014 10.1093/ijnp/pyu002 GPR39 (zinc receptor) knockout mice exhibit depression-like behavior and CREB/BDNF down-regulation in the hippocampus
Brain Res. Morales-Medina 1314 194 2010 10.1016/j.brainres.2009.09.077 A possible role of neuropeptide Y in depression and stress
Psychosom. Med. Morgan 63 412 2001 10.1097/00006842-200105000-00010 Relationship among plasma cortisol, catecholamines, neuropeptide Y, and human performance during exposure to uncontrollable stress
Biol. Psychiatr. Morgan 47 902 2000 10.1016/S0006-3223(99)00239-5 Plasma neuropeptide-Y concentrations in humans exposed to military survival training
Lancet Murray 349 1436 1997 10.1016/S0140-6736(96)07495-8 Global mortality, disability, and the contribution of risk factors: Global burden of disease study
Psychopharmacol. Bull. National Institute of Mental Health 21 1069 1985 TESS (Treatment Emergent Symptom Scale-Write In)
J. Clin. Psychiatr. Nutt 69 Suppl., E1 4 2008 Relationship of neurotransmitters to the symptoms of major depressive disorder
Planta Medica Olsson 75 105 2009 10.1055/s-0028-1088346 A randomized double-blind placebo controlled parallell group study of SHR-5 extract of Rhodiola rosea roots as treatment for patients with stress related fatigue
Psychiatr. Clin. North Am. Panossian 36 49 2013 10.1016/j.psc.2012.12.005 Adaptogens in mental and behavioral disorders
Drug Targets Insights Panossian 1 39 2007 The Adaptogens Rhodiola and Schizandra modify the response to immobilization stress in rabbits by suppressing the increase of phosphorylated stress-activated protein kinase, nitric oxide and cortisol
Phytomedicine Panossian 21 1325 2014 10.1016/j.phymed.2014.07.008 Mechanism of action of Rhodiola, salidroside, tyrosol and triandrin in isolated neuroglial cells: an interactive pathway analysis of the downstream effects using RNA microarray data
Front. Neurosci. Panossian 7 16 2013 10.3389/fnins.2013.00016 Synergy and antagonism of active constituents of ADAPT-232 on transcriptional level of metabolic regulation in isolated neuroglia cells
Phytother. Res. Panossian 23 351 2008 10.1002/ptr.2631 Pharmacokinetic and pharmacodynamic study of interaction of Rhodiola rosea SHR-5 extract with warfarin and theophylline in rats
Phytomedicine Panossian 15 1 84 2008 10.1016/j.phymed.2007.10.003 Comparative study of Rhodiola preparations on behavioral despair of rats
Phytother Res Panossian 19 819 2005 10.1002/ptr.1751 Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration
Front. Neurosci. Panossian 6 6 2012 10.3389/fnins.2012.00006 Adaptogens stimulate neuropeptide Y and Hsp72 expression and release in neuroglia cells
Arquivos Brasileiros de Fitomedicina Científica Panossian 2 108 2005 Effect of adaptogens on the central nervous system
Panossian 203 2014 Rhodiola Rosea Evidence based efficacy and effectiveness of Rhodiola SHR-5 extract in treating stress- and age-associated disorders
Pharmaceuticals Panossian 3 188 2010 10.3390/ph3010188 Effects of adaptogens on the central nervous system and the molecular mechanisms associated with their stress-protective activity
Phytomedicine Panossian 17 481 2010 10.1016/j.phymed.2010.02.002 Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy
Phytother. Res. Perfumi 21 37 2007 10.1002/ptr.2013 Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice
Acta Physiol. Pharmacol. (Bulgaria) Petkov 12 3 1986 Effects of alcohol aqueous extract from Rhodiola rosea L. roots on learning and memory
Eksp. Biol. Med. Prodius 123 629 1997 Adaptogen ADAPT modulates synthesis of inducible stress protein HSP 70 and increases organism resistance to heat shock, Biull
Zhongguo Zhong Yao Za Zhi. Qin 33 23 2842 2008 Effects of Rhodiola rosea on level of 5-hydroxytryptamine, cell proliferation and differentiation, and number of neuron in cerebral hippocampus of rats with depression induced by chronic mild stress
Neuropharmacology Quarta 60 328 2011 10.1016/j.neuropharm.2010.09.016 Central administration of NPY or an NPY-Y5 selective agonist increase in vivo extracellular monoamine levels in mesocorticolimbic projecting areas
Neuropsychopharmacology Redrobe 26 615 2002 10.1016/S0893-133X(01)00403-1 The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test
Soc. Psychiatr. Psychiatr. Epidemiol Rezvyy 40 316 2005 10.1007/s00127-005-0894-1 A comparative study of diagnostic practice in psychiatry in Northern Norway and Northwest Russia
Rhizome and roots of Rhodiola rosea 2 (1) 317 1990 Pharmacopoeia paper 75
Prim. Care Update Ob. Gyns. Richardson 1 7 215 2000 10.1016/S1068-607X(00)00049-4 Menopause and depression: a review of psychologic function and sex steroid neurobiology during the menopause
Phytochemistry Rohloff 59 655 2002 10.1016/S0031-9422(02)00004-3 Volatiles from rhizomes of Rhodiola rosea L
Controlled Clin. Trials Rush 25 119 2004 10.1016/S0197-2456(03)00112-0 STAR*D investigators group: sequenced treatment alternatives to relieve depression (STAR*D): rationale and design
Am. J. Psychiatr. Rush 163 1905 2006 10.1176/ajp.2006.163.11.1905 Acute and longer-term outcomes in depressed outpatients who required one or several treatment steps: A STAR*D report
Sandberg 131 1993 Fytoterapi: Vaxbaserade Lakemedel [Remedies based on herbs
Sandberg 223 1998 Herbal Remedies and Herb Magic
J Biol Sci Saratikov 6 142 1978 Effect of golden root extract on processes of serotonin synthesis in CNS
Saratikov 292 2004 Rhodiola rosea (Golden root) Forth edition, Revised and Enlarged
Saratikov 126 1973 The Golden Root (Rhodiola rosea)
Vestnik. Sibirskog Otdeleniya, USSR Acad. Sci. Saratikov 8 120 1965 The stimulating effect of Rhodiola rosea on the higher brain structures
Free Radic. Biol. Med. Schriner 47 577 2009 10.1016/j.freeradbiomed.2009.05.025 Protection of human cultured cells against oxidative stress by Rhodiola rosea without activation of antioxidant defenses
Med. Physiol. CR Acad. Bulg. Sci. Stancheva 40 85 1987 Effect of the extract of Rhodiola rosea L. on the content of the brain biogenic monoamines
Eur. J. Pharmacol. Stogner 387 R9 2000 10.1016/S0014-2999(99)00800-6 Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats
J. Altern. Complement Med. Stratton 25 2008 Toward a sociological understanding of complementary and alternative medicine use
Sudakov 2 61 1986 The role of adaptogens in the psychoprophylaxis of patients with borderline states of exogenous-organic genesis
Altern. Ther. Health Med. Tindle 11 42 2005 Trends in use of complementary and alternative medicine by U.S. adults: 1997-2002
Am. J. Psychiatr. Unützer 157 1851 2000 10.1176/appi.ajp.157.11.1851 Mental disorders and the use of alternative medicine: Results from a national survey
J. Ethnopharmacol. van Diermen 122 397 2009 10.1016/j.jep.2009.01.007 Monoamine oxidase inhibition by rhodiola rosea L. roots
Neurochem. Int Vásquez 79 88 2014 10.1016/j.neuint.2014.09.007 NMDA receptor dysregulation in chronic state: a possible mechanism underlying depression with BDNF downregulation
Neuropsychopharmacology Wang 30 242 2005 10.1038/sj.npp.1300606 Inhibition of Jun N-terminal kinase (JNK) enhances glucocorticoid receptor-mediated function in mouse hippocampal HT22 cells
Wiegant vol. 5 319 2008 Plant adaptogens activate cellular adaptive mechanisms by causing mild damage
Biogerontology Wiegant 10 27 2009 10.1007/s10522-008-9151-9 Plant adaptogens increase lifespan and stress resistance in C. elegans
Wikman, G., Panossian, A., 2002. Medicinal herbal extract Carpediol for treating depression. US Patent 6,905,706 B2, June 14, 2005. Filled Apr.16,2002, pp. 1-23; Published as US6905706, US20030194449, US20040131708, WO2003086430A2
Psychiatr. Serv Wu 58 349 2007 10.1176/ps.2007.58.3.349 Use of complementary and alternative medicine among women with depression: results of a national survey
Pharmacol. Biochem. Behav Yang 124 451 2014 10.1016/j.pbb.2014.07.015 Antidepressant-like effects of salidroside on olfactory bulbectomy-induced pro-inflammatory cytokine production and hyperactivity of HPA axis in rats
J. Clin. Psychiatr. Zajecka 60 389 1999 10.4088/JCP.v60n0608 Changes in adverse events reported by patients during six months of fluoxetine therapy
Neurosci. Lett. Zhu 606 1 2015 10.1016/j.neulet.2015.08.025 Salidroside attenuates lipopolysaccharide (LPS) induced serum cytokines and depressive-like behavior in mice
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.